TriLink partners with Cedarlane to enhance distribution of its products in Canada

TriLink BioTechnologies (TriLink), has entered into an agreement with Cedarlane Corporation, a Canadian based research biotechnology company, for the sale and distribution of its modified nucleoside triphosphates, custom chemistry and oligonucleotide products.

TriLink CEO, Richard Hogrefe, Ph.D. commented, "We are pleased to partner with Cedarlane to enhance the distribution of TriLink's products in Canada and the Northern US. Our product line and values fit well into the Cedarlane portfolio. Both TriLink and Cedarlane believe in providing only the highest quality products and service."

"Cedarlane is proud to add TriLink BioTechnologies' products to its extensive portfolio," said Cynthia Greer, Cedarlane President. "We are very proud of the fact that North American Scientists have an even greater opportunity to consolidate ordering from a long list of high-quality suppliers of all facets of life science research." Cynthia went on to state that, "to provide premium reagents like those from TriLink is a significant benefit to the research community due to the high volume of research taking place at the molecular level. We look forward to working with TriLink BioTechnologies to exceed the wants and needs of researchers within this marketplace."

This agreement will help advance research within the life science community as Cedarlane imports to over 25,000 scientists, making TriLink's custom nucleotides and oligonucleotides more accessible internationally to the biomedical market.

SOURCE TriLink BioTechnologies